Different roles of mast cells in obesity and diabetes: Lessons from experimental animals and humans

Frontiers in Immunology

Volumn 3, Issue JAN, 2012, Pages

  Shi, Michael A ^a   Shi, Guo Ping ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Dendritic cell; Diabetes; Diabetic nephropathy; Mast cell; Obesity; T cell

Indexed keywords

EID: 84864299769     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00007     Document Type: Review

References (157)

1. Al-Nedawi, K., Meehan, B., and Rak, J. (2009). Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8, 2014-2018.
2. Altintas, M. M., Azad, A., Nayer, B., Con- treras, G., Zaias, J., Faul, C., Reiser, J., and Nayer, A. (2011). Mast cells, macrophages, and crown-like struc- tures distinguish subcutaneous from visceral fat in mice. J. Lipid Res. 52, 480-488.
3. Altintas, M. M., Rossetti, M. M., Nayer, B., Puig, A., Zagallo, P., Ortega, L. M., Johnson, K. B., McNamara, G., Reiser, J., Mendez, A. J., and Nayer, A. (2011). Apoptosis, mas- tocytosis, and diminished adipocy- tokine gene expression accompany reduced epididymal fat mass in long- standing diet-induced obese mice. Lipids Health Dis. 10, 198.
4. Anderson, E. K., Gutierrez, D. A., and Hasty, A. H. (2010). Adi- pose tissue recruitment of leuko- cytes. Curr. Opin. Lipidol. 21, 172-177.
5. Baram, D., Vaday, G. G., Salamon, P., Drucker, I., Hershkoviz, R., and Mekori, Y. A. (2001). Human mast cells release metalloproteinase-9 on contact with activated T cells: jux- tacrine regulation by TNF-alpha. J. Immunol. 167, 4008-4016.
6. Benigni, A., Zoja, C., Campana, M., Corna, D., Sangalli, F., Rottoli, D., Gagliardini, E., Conti, S., Ledbetter, S., and Remuzzi, G. (2006). Ben- eficial effect of TGF-beta antago- nism in treating diabetic nephropa- thy depends on when treatment is started. Nephron Exp. Nephrol. 104, e158-e168.
7. Beuther, D. A. (2009). Obesity and asthma. Clin. Chest Med. 30, 479-488.
8. Bissonnette, E. Y., Enciso, J. A., and Befus, A. D. (1995). Inhibi- tion of tumour necrosis factor- alpha (TNF-alpha) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium. Clin. Exp. Immunol. 102, 78-84.
9. Bollineni, J. S., and Reddi, A. S. (1993). Transforming growth factor-beta 1 enhances glomerular collagen syn- thesis in diabetic rats. Diabetes 42, 1673-1677.
10. Bonnet, F., Cao, Z., Cooper, M. E., Cox, A. J., Kelly, D. J., and Gilbert, R. E. (2003). Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes. Diabetes Metab. 29(Pt 1), 386-392.
11. Carvalho, V. F., Barreto, E. O., Cordeiro, R. S., Lagente, V., Martins, M. A., and e Silva, P. M. (2005). Mast cell changes in experimental dia- betes: focus on attenuation of aller- gic events. Mem. Inst. Oswaldo Cruz 100(Suppl. 1), 121-125.
12. Carvalho, V. F., Barreto, E. O., Diaz, B. L., Serra, M. F., Azevedo, V., Cordeiro, R. S., Martins, M. A., and e Silva, P. M. (2003). Systemic anaphylaxis is prevented in alloxan-diabetic rats by a mechanism dependent on glu- cocorticoids. Eur. J. Pharmacol. 472, 221-227.
13. Carvalho Vde, F., Barreto Ede, O., Farias-Filho, F. A., Gomes, L. H., Mendonça Lde, L., Cordeiro, R. S., Martins, M. A., and Rodrigues e Silva, P. M. (2009). Reduced expres- sion of IL-3 mediates intestinal mast cell depletion in diabetic rats: role of insulin and glucocorticoid hormones. Int. J. Exp. Pathol. 90, 148-155.
14. Cavalher-Machado, S. C., de Lima, W. T., Damazo, A. S., de Frias Carvalho, V., Martins, M. A., e Silva, P. M., and Sannomiya, P. (2004). Down- regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin. Eur. Respir. J. 24, 552-558.
15. Clarke, C. W., and May, C. S. (1980). A comparison of the efficacy of keto- tifen (HC 20-511) with sodium cro- moglycate (SCG) in skin test positive asthma. Br. J. Clin. Pharmacol. 10, 473-476.
16. Clockaerts, S., Bastiaansen-Jenniskens, Y. M., Runhaar, J., Van Osch, G. J., Van Offel, J. F., Verhaar, J. A., De Clerck, L. S., and Somville, J. (2010). The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narra- tive review. Osteoarthr. Cartil. 18, 876-882.
17. de F Carvalho, V., Campos, L. V., Farias-Filho, F. A., Florim, L. T., Barreto, E. O., Pirmez, C., Savino, W., Martins, M. A., and e Silva, P. M. (2008). Suppression of allergic inflammatory response in the skin of alloxan-diabetic rats: relationship with reduced local mast cell num- bers. Int. Arch. Allergy Immunol. 147, 246-254.
18. de Oliveira Barreto, E., de Frias Car- valho, V., Diaz, B. L., Balduino, A., Cordeiro, R. S., Martins, M. A., and Rodrigues e Sílva, P. M. (2003). Adoptive transfer of mast cells abol- ishes the inflammatory refractori- ness to allergen in diabetic rats. Int. Arch. Allergy Immunol. 131, 212-220.
19. de Vries, V. C., Pino-Lagos, K., Nowak, E. C., Bennett, K. A., Oliva, C., and Noelle, R. J. (2011). Mast cells condition dendritic cells to medi- ate allograft tolerance. Immunity 35, 550-561.
20. Deinum, J., Tarnow, L., van Gool, J. M., de Bruin, R. A., Derkx, F. H., Schalekamp, M. A., and Parving, H. H. (1999). Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropa- thy. Nephrol. Dial. Transplant. 14, 1904-1911.
21. Diaz, B., Barreto, E., Cordeiro, R., Per- retti, M., Martins, M., and Silva, P. (2001). Enhanced serum glucocorti- coid levels mediate the reduction of serosal mast cell numbers in diabetic rats. Life Sci. 68, 2925-2932.
22. Diaz, B. L., Serra, M. F., Alves, A. C., Pires, A. L., Corrêa, F. M., Cordeiro, R. S., Martins, M. A., and e Silva, P. M. (1996). Alloxan dia- betes reduces pleural mast cell num- bers and the subsequent eosinophil influx induced by allergen in sensi- tized rats. Int. Arch. Allergy Immunol. 111, 36-43.
23. Diaz, B. L., Serra, M. F., Barreto, E. O., Cordeiro, R. S., Martins, M. A., and e Silva, P. M. (1997). Antigen-induced pleural eosinophilia is suppressed in diabetic rats: role of corticosteroid hormones. Mem. Inst. Oswaldo Cruz 92(Suppl. 2), 219-222.
24. Doggrell, S. A., and Wanstall, J. C. (2005). Cardiac chymase: patho- physiological role and therapeu- tic potential of chymase inhibitors. Can. J. Physiol. Pharmacol. 83, 123-130.
25. Douek, I. F., Leech, N. J., Gillmor, H. A., Bingley, P. J., and Gale, E. A. (1999). Children with type-1 diabetes and their unaffected siblings have fewer symptoms of asthma. Lancet 353, 1850.
26. Dudeck, A., Suender, C. A., Kostka, S. L., von Stebut, E., and Maurer, M. (2011). Mast cells promote Th1 and Th17 responses by modulating den- dritic cell maturation and function. Eur. J. Immunol. 41, 1883-1893.
27. Feldon, S. E., O'loughlin, C. W., Ray, D. M., Landskroner-Eiger, S., Sewery- niak, K. E., and Phipps, R. P. (2006). Activated human T lymphocytes express cyclooxygenase-2 and pro- duce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am. J. Pathol. 169, 1183-1193.
28. Fenger, R. V., Linneberg, A., Vidal, C., Vizcaino, L., Husemoen, L. L., Aadahl, M., and Gonzalez-Quintela, A. (2011). Determinants of serum tryptase in a general population: the relationship of serum tryptase to obesity and asthma. Int. Arch. Allergy Immunol. 157, 151-158.
29. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., and Mathis, D. (2009). Lean, but not obese, fat is enriched for a unique popula- tion of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939.
30. Finotto, S., Mekori, Y. A., and Met- calfe, D. D. (1997). Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J. Clin. Invest. 99, 1721-1728.
31. Fortes, Z. B., Farsky, S. P., Oliveira, M. A., and Garcia-Leme, J. (1991). Direct vital microscopic study of defec- tive leukocyte-endothelial interac- tion in diabetes mellitus. Diabetes 40, 1267-1273.
32. Fortes, Z. B., Garcia Leme, J., and Sciv- oletto, R. (1983). Influence of dia- betes on the reactivity of mesen- teric microvessels to histamine, bradykinin and acetylcholine. Br. J. Pharmacol. 78, 39-48.
33. Fowler, M. J. (2008). Microvascular and macrovascular complications of dia- betes. Clin. Diabetes 26, 77-82.
34. Frandji, P., Oskéritzian, C., Cacaraci, F., Lapeyre, J., Peronet, R., David, B., Guillet, J. G., and Mécheri, S. (1993). Antigen-dependent stimula- tion by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151, 6318-6328.
35. Frossi, B., D'Incà, F., Crivellato, E., Sibilano, R., Gri, G., Mongillo, M., Danelli, L., Maggi, L., and Pucillo, C. E. (2011). Single-cell dynamics of mast cell-CD4+ CD25+ regulatory T cell interactions. Eur. J. Immunol. 41, 1872-1882.
36. Gailit, J., Marchese, M. J., Kew, R. R., and Gruber, B. L. (2001). The differenti- ation and function of myofibroblasts is regulated by mast cell mediators. J. Invest. Dermatol. 117, 1113-1119.
37. Galli, S. J., Kalesnikoff, J., Grim- baldeston, M. A., Piliponsky, A. M., Williams, C. M., and Tsai, M. (2005). Mast cells as "tun- able" effector and immunoregula- tory cells: recent advances. Annu. Rev. Immunol. 23, 749-786.
38. Galli, S. J., Nakae, S., and Tsai, M. (2005). Mast cells in the develop- ment of adaptive immune responses. Nat. Immunol. 6, 135-142.
39. Geoffrey, R., Jia, S., Kwitek, A. E., Woodliff, J., Ghosh, S., Lernmark, A., Wang, X., and Hessner, M. J. (2006). Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat. J. Immunol. 177, 7275-7286.
40. Gilbert, R. E., Rumble, J. R., Cao, Z., Cox, A. J., van Eeden, P., Allen, T. J., Kelly, D.J., andCooper, M.E. (2000). Endothelin receptor antag- onism ameliorates mast cell infiltra- tion, vascular hypertrophy, and epi- dermal growth factor expression in experimental diabetes. Circ. Res. 86, 158-165.
41. Goldfarb, S., and Ziyadeh, F. N. (2001). TGF-beta: a crucial com- ponent of the pathogenesis of dia- betic nephropathy. Trans. Am. Clin. Climatol. Assoc. 112, 27-32.
42. Goldsmith, P., McGarity, B., Walls, A. F., Church, M. K., Millward- Sadler, G. H., and Robertson, D. A. (1990). Corticosteroid treatment reduces mast cell numbers in inflam- matory bowel disease. Dig. Dis. Sci. 35, 1409-1413.
43. Gonzalez-Quintela, A., Vizcaino, L., Gude, F., Rey, J., Meijide, L., Fernandez-Merino, C., Linneberg, A., and Vidal, C. (2010). Factors influencing serum total tryptase concentrations in a general adult population. Clin. Chem. Lab. Med. 48, 701-706.
44. Green, E. A., Eynon, E. E., and Flavell, R. A. (1998). Local expression of TNF-alpha in neonatal NOD mice promotes diabetes by enhancing pre- sentation of islet antigens. Immunity 9, 733-743.
45. Gri, G., Piconese, S., Frossi, B., Manfroi, V., Merluzzi, S., Tripodo, C., Viola, A., Odom, S., Rivera, J., Colombo, M. P., and Pucillo, C. E. (2008). CD4+CD25+ regulatory T cells sup- press mast cell degranulation and allergic responses through OX40- OX40L interaction. Immunity 29, 771-781.
46. Groen, H., Klatter, F., Pater, J., Nieuwen- huis, P., and Rozing, J. (2003). Tem- porary, but essential requirement of CD8+ T cells early in the patho- genesis of diabetes in BB rats as revealed by thymectomy and CD8 depletion. Clin. Dev. Immunol. 10, 141-151.
47. Hamawy, M. M., Mergenhagen, S. E., and Siraganian, R. P. (1994). Adhe- sion molecules as regulators of mast- cell and basophil function. Immunol. Today 15, 62-66.
48. Helske, S., Syväranta, S., Kupari, M., Lappalainen, J., Laine, M., Lommi, J., Turto, H., Mäyränpää, M., Werkkala, K., Kovanen, P. T., and Lindstedt, K. A. (2006). Possible role for mast cell- derived cathepsin G in the adverse remodelling of stenotic aortic valves. Eur. Heart J. 27, 1495-1504.
49. Herlong, J. L., and Scott, T. R. (2006). Positioning prostanoids of the D and J series in the immunopatho- genic scheme. Immunol. Lett. 102, 121-131.
50. Hersoug, L. G., and Linneberg, A. (2007). The link between the epi- demics of obesity and allergic dis- eases: does obesity induce decreased immune tolerance? Allergy 62, 1205-1213.
51. Hessner, M. J., Wang, X., Meyer, L., Geoffrey, R., Jia, S., Fuller, J., Lern- mark, A., and Ghosh, S. (2004). Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the BioBreeding rat. J. Immunol. 173, 6993-7002.
52. Hotamisligil, G. S., Shargill, N. S., and Spiegelman, B. M. (1993). Adi- pose expression of tumor necrosis factor-alpha: direct role in obesity- linked insulin resistance. Science 259, 87-91.
53. Huang, S. W. (1999). Asthma and dia- betes. Lancet 354, 515.
54. Huang, Y., Noble, N. A., Zhang, J., Xu, C., and Border, W. A. (2007). Renin- stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 72, 45-52.
55. Hübner, M. P., Larson, D., Torrero, M. N., Mueller, E., Shi, Y., Killoran, K. E., and Mitre, E. (2011). Anti- FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice. Clin. Immunol. 141, 205-217.
56. Inamura, N., Mekori, Y. A., Bhat- tacharyya, S. P., Bianchine, P. J., and Metcalfe, D. D. (1998). Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: depen- dency on ICAM-1- and leukocyte function-associated antigen (LFA)- 1-mediated heterotypic aggregation. J. Immunol. 160, 4026-4033.
57. Irani, A. M., Nilsson, G., Miettinen, U., Craig, S. S., Ashman, L. K., Ishizaka, T., Zsebo, K. M., and Schwartz, L. B. (1992). Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80, 3009-3021.
58. Ishida, K., Takai, S., Murano, M., Nishikawa, T., Inoue, T., Murano, N., Inoue, N., Jin, D., Umegaki, E., Higuchi, K., and Miyazaki, M. (2008). Role of chymase-dependent matrix metalloproteinase-9 activa- tion in mice with dextran sodium sulfate-induced colitis. J. Pharmacol. Exp. Ther. 324, 422-426.
59. Jakschik, B. A., Rengers, T. A., and Pinski, J. R. (1987). Nature of the mast cell-macrophage interaction in immediate hypersensitivity. Adv. Prostaglandin Thromboxane Leukot. Res. 17A, 180-185.
60. Jones, S. E., Gilbert, R. E., and Kelly, D. J. (2004). Tranilast reduces mesen- teric vascular collagen deposition and chymase-positive mast cells in experimental diabetes. J. Diabetes Complicat. 18, 309-315.
61. Kalantarinia, K., Awad, A. S., and Sir- agy, H. M. (2003). Urinary and renal interstitial concentrations of TNF- alpha increase prior to the rise in albuminuria in diabetic rats. Kidney Int. 64, 1208-1213.
62. Kalesnikoff, J., and Galli, S. J. (2008). New developments in mast cell biol- ogy. Nat. Immunol. 9, 1215-1223.
63. Kashyap, M., Thornton, A. M., Norton, S. K., Barnstein, B., Macey, M., Bren- zovich, J., Shevach, E., Leonard, W. J., and Ryan, J. J. (2008). Cutting edge: CD4 T cell-mast cell inter- actions alter IgE receptor expres- sion and signaling. J. Immunol. 180, 2039-2043.
64. Kaur, D., Doe, C., Woodman, L., Wan, H., Sutcliffe, A., Hollins, F., and Brightling, C. (2011). Mast cell- airway smooth muscle crosstalk: the role of thymic stromal lymphopoi- etin. Chest. doi: 10.1378/chest.11- 1782. [Epub ahead of print].
65. Kelly, D. J., Zhang, Y., Moe, G., Naik, G., and Gilbert, R. E. (2007). Aliskiren, a novel renin inhibitor, is renoprotec- tive in a model of advanced diabetic nephropathy in rats. Diabetologia 50, 2398-2404.
66. Kettner, A., DiMatteo, M., and San-toni, A. (2010). Insulin potentiates Fc epsilon RI-mediated signalingin mouse bone marrow-derived mast cells. Mol.Immunol. 47, 1039-1046. Kikutani, H., and Makino, S. (1992). The murine autoimmune diabetes model: NOD and related strains. Adv.Immunol. 51, 285-322.
67. Kettner, A., Di Matteo, M., and San- toni, A. (2010). Insulin potentiates Fc epsilon RI-mediated signaling in mouse bone marrow-derived mast cells. Mol. Immunol. 47, 1039-1046. Kikutani, H., and Makino, S. (1992). The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51, 285-322.
68. Kitaura, J., Eto, K., Kinoshita, T., Kawakami, Y., Leitges, M., Lowell, C. A., and Kawakami, T. (2005). Reg- ulation of highly cytokinergic IgE- induced mast cell adhesion by Src, Syk, Tec, and protein kinase C family kinases. J. Immunol. 174, 4495-4504.
69. Klein-Wieringa, I. R., Kloppenburg, M., Bastiaansen-Jenniskens, Y. M., Yusuf, E., Kwekkeboom, J. C., El-Bannoudi, H., Nelissen, R. G., Zuurmond, A., Stojanovic-Susulic, V., Van Osch, G. J., Toes, R. E., and Ioan-Facsinay, A. (2011). The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann. Rheum. Dis. 70, 851-857.
70. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., and Lehmann, J. M. (1995). A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83, 813-819.
71. Koda, A., Kurashina, Y., and Nakazawa, M. (1985). The inhibition mech- anism of histamine release by N-(3, 4-dimethoxycinnamoyl) anthranilic acid. Int. Arch. Allergy Appl. Immunol. 77, 244-245.
72. Kondo, S., Kagami, S., Kido, H., Strutz, F., Müller, G. A., and Kuroda, Y. (2001). Role of mast cell tryptase in renal interstitial fibrosis. J. Am. Soc. Nephrol. 12, 1668-1676.
73. Kotani, A., Hori, T., Fujita, T., Kambe, N., Matsumura, Y., Ishikawa, T., Miy- achi, Y., Nagai, K., Tanaka, Y., and Uchiyama, T. (2007). Involvement of OX40 ligand+ mast cells in chronic GVHD after allogeneic hematopoi- etic stem cell transplantation. Bone Marrow Transplant. 39, 373-375.
74. Kovanen, P. T. (2007). Mast cells: multipotent local effector cells in atherothrombosis. Immunol. Rev. 217, 105-122.
75. Koyama, S., Takagi, H., Otani, A., Suzuma, K., Nishimura, K., and Honda, Y. (1999). Tranilast inhibits protein kinase C-dependent sig- nalling pathway linked to angio- genic activities and gene expression of retinal microcapillary endothe- lial cells. Br. J. Pharmacol. 127, 537-545.
76. Kukreja, A., and Maclaren, N. K. (1999). Autoimmunity and diabetes. J. Clin. Endocrinol. Metab. 84, 4371-4378.
77. Lessmann, E., Grochowy, G., Wein- garten, L., Giesemann, T., Akto- ries, K., Leitges, M., Krystal, G., and Huber, M. (2006). Insulin and insulin-like growth factor-1 pro- mote mast cell survival via activa- tion of the phosphatidylinositol-3- kinase pathway. Exp. Hematol. 34, 1532-1541.
78. Levick, S. P., McLarty, J. L., Murray, D. B., Freeman, R. M., Carver, W. E., and Brower, G. L. (2009). Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. Hypertension 53, 1041-1047.
79. Liu, J., Divoux, A., Sun, J., Zhang, J., Clé- ment, K., Glickman, J. N., Sukhova, G. K., Wolters, P. J., Du, J., Gorgun, C. Z., Doria, A., Libby, P., Blum- berg, R. S., Kahn, B. B., Hotamis- ligil, G. S., and Shi, G. P. (2009). Genetic deficiency and pharmaco- logical stabilization of mast cells reduce diet-induced obesity and dia- betes in mice. Nat. Med. 15, 940-945.
80. Lu, L. F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino- Lagos, K., Scott, Z. A., Coyle, A. J., Reed, J. L., Van Snick, J., Strom, T. B., Zheng, X. X., and Noelle, R. J. (2006). Mast cells are essential intermedi- aries in regulatory T-cell tolerance. Nature 442, 997-1002.
81. Ludvik, B., Clodi, M., Kautzky-Willer, A., Capek, M., Hartter, E., Pacini, G., and Prager, R. (1993). Effect of dexamethasone on insulin sensitiv- ity, islet amyloid polypeptide and insulin secretion in humans. Dia- betologia 36, 84-87.
82. Macia, L., Delacre, M., Abboud, G., Ouk, T. S., Delanoye, A., Verwaerde, C., Saule, P., and Wolowczuk, I. (2006). Impairment of dendritic cell func- tionality and steady-state number in obese mice. J. Immunol. 177, 5997-6006.
83. Mahmoud, R. A., el-Ezz, S. A., and Hegazy, A. S. (2004). Increased serum levels of interleukin-18 in patients with diabetic nephropathy. Ital. J. Biochem. 53, 73-81.
84. Maltby, S., Khazaie, K., and McNagny, K. M. (2009). Mast cells in tumor growth: angiogenesis, tissue remod- elling and immune-modulation. Biochim. Biophys. Acta. 1796, 19-26.
85. Marshall, J. S., Gomi, K., Blennerhas- sett, M. G., and Bienenstock, J. (1999). Nerve growth factor mod- ifies the expression of inflamma- tory cytokines by mast cells via a prostanoid-dependent mechanism. J. Immunol. 162, 4271-4276.
86. Mathis, D., Vence, L., and Benoist, C. (2001). Beta-cell death during pro- gression to diabetes. Nature 414, 792-798.
87. Mekori, Y. A. (2004). The masto- cyte: the "other" inflammatory cell in immunopathogenesis. J. Allergy Clin. Immunol. 114, 52-57.
88. Mekori, Y. A., Oh, C. K., and Met- calfe, D. D. (1993). IL-3-dependent murine mast cells undergo apop- tosis on removal of IL-3. Preven- tion of apoptosis by c-kit ligand. J. Immunol. 151, 3775-3784.
89. Metcalfe, D. D. (2008). Mast cells and mastocytosis. Blood 112, 946-956.
90. Metcalfe, D. D., Baram, D., and Mekori, Y. A. (1997). Mast cells. Physiol. Rev. 77, 1033-1079.
91. Mifsud, S., Kelly, D. J., Qi, W., Zhang, Y., Pollock, C. A., Wilkinson-Berka, J. L., and Gilbert, R. E. (2003). Intervention with tranilast attenu- ates renal pathology and albumin- uria in advanced experimental dia- betic nephropathy. Nephron Physiol. 95, p83-p91.
92. Mirmonsef, P., Shelburne, C. P., Fitzhugh Yeatman, C. II, Chong, H. J., and Ryan, J. J. (1999). Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3′-kinase. J. Immunol. 163, 2530-2539.
93. Mordes, J. P., Bortell, R., Doukas, J., Rigby, M., Whalen, B., Zipris, D., Greiner, D. L., and Rossini, A. A. (1996). The BB/Wor rat and the balance hypothesis of autoim- munity. Diabetes Metab. Rev. 12, 103-109.
94. Moriwaki, Y., Inokuchi, T., Yamamoto, A., Ka, T., Tsutsumi, Z., Takahashi, S., and Yamamoto, T. (2007). Effect of TNF-alpha inhibition on urinary albumin excretion in experimen- tal diabetic rats. Acta Diabetol. 44, 215-218.
95. Murano, I., Barbatelli, G., Parisani, V., Latini, C., Muzzonigro, G., Castel- lucci, M., and Cinti, S. (2008). Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J. Lipid Res. 49, 1562-1568.
96. Musilli, C., Paccosi, S., Pala, L., Gerlini, G., Ledda, F., Mugelli, A., Rotella, C. M., and Parenti, A. (2011). Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patients. Mol. Immunol. 49, 234-238.
97. Nakamura, T., Fukui, M., Ebihara, I., Osada, S., Nagaoka, I., Tomino, Y., and Koide, H. (1993). mRNA expres- sion of growth factors in glomeruli from diabetic rats. Diabetes 42, 450-456.
98. Nakano, T., Sonoda, T., Hayashi, C., Yamatodani, A., Kanayama, Y., Yama- mura, T., Asai, H., Yonezawa, T., Kita- mura, Y., and Galli, S. J. (1985). Fate of bone marrow-derived cul- tured mast cells after intracuta- neous, intraperitoneal, and intra- venous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162, 1025-1043.
99. Navarro, J. F., Mora, C., Maca, M., and Garca, J. (2003). Inflammatory para- meters are independently associated with urinary albumin in type 2 dia- betes mellitus. Am. J. Kidney Dis. 42, 53-61.
100. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., Yoshimura, K., Kad- owaki, T., and Nagai, R. (2009). CD8+ effector T cells contribute to macrophage recruitment and adi- pose tissue inflammation in obesity. Nat. Med. 15, 914-920.
101. Nocka, K., Buck, J., Levi, E., and Besmer, P. (1990). Candidate ligand for the c-kit transmembrane kinase recep- tor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J. 9, 3287-3294.
102. Ochi, M., Sawada, T., Kusunoki, T., and Hattori, T. (1988). Morphology and cell dynamics of adipose tissue in hypothalamic obese mice. Am. J. Physiol. 254(Pt 2), R740-R745.
103. Ohmura, K., Ishimori, N., Ohmura, Y., Tokuhara, S., Nozawa, A., Horii, S., Andoh, Y., Fujii, S., Iwabuchi, K., Onoé, K., and Tsutsui, H. (2010). Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler. Thromb. Vasc. Biol. 30, 193-199.
104. Okon, K., and Stachura, J. (2007). Increased mast cell density in renal interstitium is correlated with rela- tive interstitial volume, serum crea- tinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis. Pol. J. Pathol. 58, 193-197.
105. Otton, R., Soriano, F. G., Verlengia, R., and Curi, R. (2004). Diabetes induces apoptosis in lymphocytes. J. Endocrinol. 182, 145-156.
106. Ozsoy, N., and Gül, N. (2005). Char- acterization of the ultrastructure of gingival mast cells in alloxan- induced diabetic rats. Cell Biochem. Funct. 23, 333-337.
107. Piconese, S., Gri, G., Tripodo, C., Musio, S., Gorzanelli, A., Frossi, B., Pedotti, R., Pucillo, C. E., and Colombo, M. P. (2009). Mast cells counteract reg- ulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 114, 2639-2648.
108. Pipkorn, U., Hammarlund, A., and Enerbäck, L. (1989). Prolonged treatment with topical glucocorti- coids results in an inhibition of the allergen-induced weal-and-flare response and a reduction in skin mast cell numbers and histamine content. Clin. Exp. Allergy 19, 19-25.
109. Poglio, S., De Toni-Costes, F., Arnaud, E., Laharrague, P., Espinosa, E., Casteilla, L., and Cousin, B. (2010). Adipose tissue as a dedicated reser- voir of functional mast cell progeni- tors. Stem Cells 28, 2065-2072.
110. Ptak, W., Rewicka, M., Strzyzewska, J., and Kollat, M. (1983). Alleviation of IgE-mediated immune reactions in hypoinsulinaemic and hypergly- caemic mice. Clin. Exp. Immunol. 52, 54-60.
111. Ritz, E. (2003). Chymase: a potential culprit in diabetic nephropathy? J. Am. Soc. Nephrol. 14, 1952-1954.
112. Rüger, B. M., Hasan, Q., Greenhill, N. S., Davis, P. F., Dunbar, P. R., and Neale, T. J. (1996). Mast cells and type VIII collagen in human dia- betic nephropathy. Diabetologia 39, 1215-1222.
113. Russo, L. M., del Re, E., Brown, D., and Lin, H. Y. (2007). Evidence for a role of transforming growth fac- tor (TGF)-beta1 in the induction of postglomerular albuminuria in dia- betic nephropathy: amelioration by soluble TGF-beta type II receptor. Diabetes 56, 380-388.
114. Ryan, J. J., DeSimone, S., Klisch, G., Shel- burne, C., McReynolds, L. J., Han, K., Kovacs, R., Mirmonsef, P., and Huff, T. F. (1998). IL-4 inhibits mouse mast cell Fc epsilon RI expres- sion through a STAT6-dependent mechanism. J. Immunol. 161, 6915-6923.
115. Salamon, P., Shoham, N. G., Puxeddu, I., Paitan, Y., Levi-Schaffer, F., and Mekori, Y. A. (2008). Human mast cells release oncostatin M on con- tact with activated T cells: possible biologic relevance. J. Allergy Clin. Immunol. 121, 448-455.
116. Sato, H., Iwano, M., Akai, Y., Kurioka, H., Kubo, A., Yamaguchi, T., Hirata, E., Kanauchi, M., and Dohi, K. (1998). Increased excretion of urinary trans- forming growth factor beta 1 in patients with diabetic nephropathy. Am.J.Nephrol.18, 490-494.
117. Sayed, B. A., and Brown, M. A. (2007). Mast cells as modulators of T- cell responses. Immunol. Rev. 217, 53-64.
118. Schleimer, R. P. (1993). An overview of glucocorticoid anti-inflammatory actions. Eur. J. Clin. Pharmacol. 45(Suppl. 1), S3-S7.
119. Schwertschlag, U., and Hackenthal, E. (1982). Histamine stimulates renin release from the isolated perfused rat kidney. Naunyn Schmiedebergs Arch. Pharmacol. 319, 239-242.
120. Shefler, I., Salamon, P., Reshef, T., Mor, A., and Mekori, Y. A. (2010). T cell-induced mast cell activation: a role for microparticles released from activated T cells. J. Immunol. 185, 4206-4212.
121. Shi, M. A., and Shi, G. P. (2010). Intracellular delivery strategies for microRNAs and potential therapies for human cardiovascular diseases. Sci. Signal. 3, pe40.
122. Shore, S. A. (2010). Obesity, airway hyperresponsiveness, and inflam- mation. J. Appl. Physiol. 108, 735-743.
123. Silver, R. B., Reid, A. C., Mackins, C. J., Askwith, T., Schaefer, U., Her- zlinger, D., and Levi, R. (2004). Mast cells: a unique source of renin. Proc. Natl. Acad. Sci. U.S.A. 101, 13607-13612.
124. Smith, A. G., Sheridan, P. A., Tseng, R. J., Sheridan, J. F., and Beck, M. A. (2009). Selective impair- ment in dendritic cell function and altered antigen-specific CD8+ T- cell responses in diet-induced obese mice infected with influenza virus. Immunology 126, 268-279.
125. Soma, J., Sugawara, T., Huang, Y. D., Nakajima, J., and Kawamura, M. (2002). Tranilast slows the progres- sion of advanced diabetic nephropa- thy. Nephron 92, 693-698.
126. Spiecker, M., Lorenz, I., Marx, N., and Darius, H. (2002). Tranilast inhibits cytokine-induced nuclear factor kappaB activation in vascular endothelial cells. Mol. Pharmacol. 62, 856-863.
127. St. John, A. L., Rathore, A. P., Yap, H., Ng, M. L., Metcalfe, D. D., Vasudevan, S. G., and Abraham, S. N. (2011). Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc. Natl. Acad. Sci. U.S.A. 108, 9190-9195.
128. Stelekati, E., Bahri, R., D'Orlando, O., Orinska, Z., Mittrücker, H. W., Lan- genhaun, R., Glatzel, M., Bollinger, A., Paus, R., and Bulfone-Paus, S. (2009). Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 31, 665-676.
129. Sun, J., Sukhova, G. K., Wolters, P. J., Yang, M., Kitamoto, S., Libby, P., MacFarlane, L. A., Mallen-St Clair, J., and Shi, G. P. (2007). Mast cells promote atherosclerosis by releas- ing proinflammatory cytokines. Nat. Med. 13, 719-724.
130. Sun, J., Sukhova, G. K., Yang, M., Wolters, P. J., MacFarlane, L. A., Libby, P., Sun, C., Zhang, Y., Liu, J., Ennis, T. L., Knispel, R., Xiong, W., Thompson, R. W., Baxter, B. T., and Shi, G. P. (2007). Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J. Clin. Invest. 117, 3359-3368.
131. Suto, H., Nakae, S., Kakurai, M., Sedg- wick, J. D., Tsai, M., and Galli, S. J. (2006). Mast cell-associated TNF promotes dendritic cell migration. J. Immunol. 176, 4102-4112.
132. Suzawa, H., Kikuchi, S., Ichikawa, K., and Koda, A. (1992). Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes- macrophages. Jpn. J. Pharmacol. 60, 85-90.
133. Taguchi, S., Ozaki, N., Umeda, H., Mizu- tani, N., Yamada, T., and Oiso, Y. (2008). Tranilast inhibits glucose- induced insulin secretion from pan- creatic beta-cells. Horm. Metab. Res. 40, 518-523.
134. Tanaka, A., Nomura, Y., Matsuda, A., Ohmori, K., and Matsuda, H. (2011). Mast cells function as an alter- native modulator of adipogene- sis through 15-deoxy-delta-12, 14- prostaglandin J2. Am. J. Physiol. Cell Physiol. 301, C1360-C1367.
135. Tedgui, A., Owens, A. P. III, and Mackman, N. (2011). Nobel prize in physiology or medicine: toll- like receptors, dendritic cells, and their roles in atherosclerosis. Arte- rioscler. Thromb. Vasc. Biol. 31, 2767-2768.
136. Théry, C., Ostrowski, M., and Segura, E. (2009). Membrane vesicles as con- veyors of immune responses. Nat. Rev. Immunol. 9, 581-593.
137. Tilg, H., and Moschen, A. R. (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772-783.
138. Tóth, T., Tóth-Jakatics, R., Jimi, S., Ihara, M., Urata, H., and Take- bayashi, S. (1999). Mast cells in rapidly progressive glomeru- lonephritis. J. Am. Soc. Nephrol. 10, 1498-1505.
139. Trayhurn, P. (2005). Endocrine and sig- nalling role of adipose tissue: new perspectives on fat. Acta Physiol. Scand. 184, 285-293.
140. Uysal, K. T., Wiesbrock, S. M., Marino, M. W., and Hotamisligil, G. S. (1997). Protection from obesity- induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610-614.
141. Vianna, E. O., and Garcia-Leme, J. (1995). Allergen-induced airway inflammation in rats. Role of insulin. Am. J. Respir. Crit. Care Med. 151(Pt 1), 809-814.
142. Wallis, R. H., Wang, K., Marandi, L., Hsieh, E., Ning, T., Chao, G. Y., Sarmiento, J., Paterson, A. D., and Poussier, P. (2009). Type 1 diabetes in the BB rat: a polygenic disease. Diabetes 58, 1007-1017.
143. Wang, Z., Zhang, H., Shen, X. H., Jin, K. L., Ye, G. F., Qian, L., Li, B., Zhang, Y. H., and Shi, G. P. (2012). Immunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus. PLoS ONE 6, e28962.
144. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, A. W. Jr. (2003). Obesity is associated with macrophage accu- mulation in adipose tissue. J. Clin. Invest. 112, 1796-1808.
145. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., and Tataranni, P. A. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperin- sulinemia. J. Clin. Endocrinol. Metab. 86, 1930-1935.
146. Wilson, T. J., Nannuru, K. C., and Singh, R. K. (2009). Cathepsin G- mediated activation of pro-matrix metalloproteinase 9 at the tumor- bone interface promotes transform- ing growth factor-beta signaling and bone destruction. Mol. Cancer Res. 7, 1224-1233.
147. Winer, D. A., Winer, S., Shen, L., Wadia, P. P., Yantha, J., Paltser, G., Tsui, H., Wu, P., Davidson, M. G., Alonso, M. N., Leong, H. X., Glassford, A., Caimol, M., Kenkel, J. A., Tedder, T. F., McLaughlin, T., Miklos, D. B., Dosch, H. M., and Engleman, E. G. (2011). B cells promote insulin resistance through modulation of T cells and production of patho- genic IgG antibodies. Nat. Med. 17, 610-617.
148. Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mas- tronardi, F., Maezawa, Y., Drucker, D. J., Engleman, E., Winer, D., and Dosch, H. M. (2009). Normalization of obesity-associated insulin resis- tance through immunotherapy. Nat. Med. 15, 921-929.
149. Wolf, G., and Ziyadeh, F. N. (1999). Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 56, 393-405.
150. Wolf, G., and Ziyadeh, F. N. (2007). Cel- lular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol. 106, p26-p31.
151. Wu, D., Molofsky, A. B., Liang, H. E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., Chawla, A., and Locksley, R. M. (2011). Eosinophils sustain adipose alternatively acti- vated macrophages associated with glucose homeostasis. Science 332, 243-247.
152. Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., and Chen, H. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity- related insulin resistance. J. Clin. Invest. 112, 1821-1830.
153. Xu, J., and Shi, G. P. (2012). Emerging role of mast cells and macrophages in cardiovascular and metabolic dis- eases. Endocr. Rev. (in press).
154. Yamada, H., Tajima, S., Nishikawa, T., Murad, S., and Pinnell, S. R. (1994). Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J. Biochem. 116, 892-897.
155. Yeatman, C. F. II, Jacobs-Helber, S. M., Mirmonsef, P., Gillespie, S. R., Bou- ton, L. A., Collins, H. A., Sawyer, S. T., Shelburne, C. P., and Ryan, J. J. (2000). Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. J. Exp. Med. 192, 1093-1103.
156. Zhang, B., Alysandratos, K. D., Angeli- dou, A., Asadi, S., Sismanopou- los, N., Delivanis, D. A., Weng, Z., Miniati, A., Vasiadi, M., Katsarou- Katsari, A., Miao, B., Leeman, S. E., Kalogeromitros, D., and Theo- harides, T. C. (2011). Human mast cell degranulation and preformed TNF secretion require mitochon- drial translocation to exocytosis sites: relevance to atopic dermati- tis. J. Allergy Clin. Immunol. 127, 1522-1531.
157. Zhang, J., Alcaide, P., Liu, L., Sun, J., He, A., Luscinskas, F. W., and Shi, G. P. (2011). Regulation of endothe- lial cell adhesion molecule expres- sion by mast cells, macrophages, and neutrophils. PLoS ONE 6, e14525. doi:10.1371/journal.pone.0014525